Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07020520 · ClinicalTrials.gov registry record · NA
EvaluatioN of Optilume Drug-Coated Balloon for the Endoscopic Treatment of UREteric Strictures
A NA study of Ureteral Stricture, sponsored by Urotronic.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 7
- Study locations
NCT07020520 is a NA study of Ureteral Stricture that is actively recruiting participants, run by Urotronic. The registered enrollment target is 60 participants. The trial reports 7 study locations across 6 states.
The verdict
NCT07020520, a NA study of Ureteral Stricture, is actively recruiting participants, sponsored by Urotronic.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 7
- Study locations
Study Summary
The main objective of this clinical investigation is to assess the safety and feasibility of the Optilume DCB for treatment of ureteric strictures.
Conditions Studied
Interventions
- DEVICE Optilume
Study Locations (7)
New York
- Mount Sinai - New York
- NYU Langone - New York
California
- University of California Irvine - Orange
Florida
- Orlando Health - Orlando
Indiana
- Indiana University - Indianapolis
Texas
- University of Texas Southwestern - Dallas
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-10-01 |
| Est. Completion | 2031-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07020520
The ClinicalTrials.gov registry entry for NCT07020520 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Urotronic, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ureteral Stricture appearing as the primary indexed condition, and to 1 intervention - of which Optilume is the first listed.
NCT07020520 reports 7 study locations spanning 6 distinct geographic areas - top geographies include New York, California, Florida.
Frequently Asked Questions
What is clinical trial NCT07020520 about?
NCT07020520 is a clinical study titled "EvaluatioN of Optilume Drug-Coated Balloon for the Endoscopic Treatment of UREteric Strictures". The main objective of this clinical investigation is to assess the safety and feasibility of the Optilume DCB for treatment of ureteric strictures.
What is the current status of trial NCT07020520?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-10-01. Estimated completion is 2031-07-30.
What conditions does trial NCT07020520 study?
This clinical trial studies the following conditions: Ureteral Stricture.
What interventions are being tested in trial NCT07020520?
The interventions under investigation include: Optilume (DEVICE).
Who is sponsoring clinical trial NCT07020520?
This trial is sponsored by Urotronic, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07020520 being conducted?
This trial has 7 study locations across California, Florida, Indiana, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ureteral Stricture
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.